Variant report
Variant | esv2760115 |
---|---|
Chromosome Location | chr10:37663400-37685064 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:7)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:7 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ANKRD30A-3 | chr10:37667410-37668609 | NONHSAT012774 |
2 | lnc-ANKRD30A-5 | chr10:37684461-37685164 | NONHSAT012776 |
3 | lnc-ANKRD30A-3 | chr10:37668727-37669260 | NONHSAT012774 |
4 | lnc-ANKRD30A-3 | chr10:37669590-37669641 | NONHSAT012774 |
5 | lnc-ANKRD30A-5 | chr10:37684566-37684681 | XLOC_008455 |
6 | lnc-ANKRD30A-3 | chr10:37668110-37668180 | XLOC_008454 |
7 | lnc-ANKRD30A-3 | chr10:37668779-37669239 | XLOC_008454 |
No data |
No data |
Variant related genes | Relation type |
---|---|
PTEN | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12783534 | chr10:37663400-37663401 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs187502955 | chr10:37663408-37663409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138316655 | chr10:37663437-37663438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs111533109 | chr10:37663438-37663439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565329882 | chr10:37663441-37663442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555670965 | chr10:37667417-37667418 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs34313110 | chr10:37667438-37667439 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs371218988 | chr10:37667477-37667478 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs143200162 | chr10:37667522-37667523 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs186251920 | chr10:37667580-37667581 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs147070938 | chr10:37667586-37667587 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs557003082 | chr10:37667605-37667606 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs555433932 | chr10:37667700-37667701 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs569386432 | chr10:37667701-37667702 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs111869131 | chr10:37667765-37667766 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs558187586 | chr10:37667777-37667778 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs1938415 | chr10:37667779-37667780 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs578169181 | chr10:37667785-37667786 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs540239877 | chr10:37667786-37667787 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs562454495 | chr10:37667816-37667817 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs553756239 | chr10:37667839-37667840 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs576935628 | chr10:37667860-37667861 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs573676443 | chr10:37667924-37667925 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs190568140 | chr10:37667960-37667961 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs149579920 | chr10:37667966-37667967 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs546332447 | chr10:37668068-37668069 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs528401999 | chr10:37668105-37668106 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs572823919 | chr10:37668205-37668206 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs117118554 | chr10:37668206-37668207 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs545154396 | chr10:37668238-37668239 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs71489137 | chr10:37668239-37668240 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs374702460 | chr10:37668245-37668246 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs182774052 | chr10:37668309-37668310 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs79519848 | chr10:37668313-37668314 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs566569199 | chr10:37668325-37668326 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs529236075 | chr10:37668330-37668331 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs372215489 | chr10:37668419-37668420 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs569304459 | chr10:37668423-37668424 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs538068675 | chr10:37668516-37668517 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs376564808 | chr10:37668550-37668551 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs185765797 | chr10:37668569-37668570 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs571850283 | chr10:37668574-37668575 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs35706720 | chr10:37668633-37668634 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs554495621 | chr10:37668634-37668635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs370141581 | chr10:37668651-37668652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs573711642 | chr10:37668661-37668662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs536227884 | chr10:37668670-37668671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs556000892 | chr10:37668674-37668675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs115348871 | chr10:37668684-37668685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs544879701 | chr10:37668704-37668705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Behavioral abnormalities | 21522184 | CNVD |
Dysmorphic features | 21522184 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Bethlem myopathy | 20302629 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Lung cancer | 21569311 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:37663200-37663600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr10:37667400-37669600 | Enhancers | A549 | lung |
3 | chr10:37667800-37669800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr10:37668200-37669600 | Enhancers | HMEC | breast |
5 | chr10:37668200-37669600 | Enhancers | NHEK | skin |
6 | chr10:37668800-37669200 | Enhancers | Muscle Satellite Cultured Cells | -- |
7 | chr10:37668800-37669400 | Enhancers | HSMM | muscle |
8 | chr10:37668800-37669600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr10:37669000-37669400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr10:37669200-37669400 | Flanking Active TSS | Muscle Satellite Cultured Cells | -- |
11 | chr10:37669400-37669600 | Enhancers | Muscle Satellite Cultured Cells | -- |
12 | chr10:37669800-37673400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr10:37674400-37675000 | Active TSS | Fetal Heart | heart |
14 | chr10:37679800-37681400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr10:37680200-37681800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |